Chordate Medical Holding AB (CMH) — Strategic Asset Allocation Index
Chordate Medical Holding AB (CMH) has a Strategic Asset Allocation Index of 2.0% as of June 2023. Strategic assets (PP&E of Skr584.25K plus long-term investments of Skr-) total Skr584.25K, measured against net assets of Skr29.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Chordate Medical Holding AB liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Chordate Medical Holding AB Strategic Asset Allocation Index (2019–2022)
This chart shows how Chordate Medical Holding AB's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 2.0%, representing strategic assets of Skr584.25K against net assets of Skr29.87 Million SEK. See CMH free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Chordate Medical Holding AB (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Chordate Medical Holding AB from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Chordate Medical Holding AB market capitalisation.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 6.1% | Skr675.45K | Skr675.45K | Skr- | Skr11.07 Million | ▲ +4.7 pp |
| 2021 | 1.4% | Skr546.08K | Skr546.08K | Skr- | Skr38.95 Million | ▼ -1.7 pp |
| 2020 | 3.1% | Skr806.20K | Skr806.20K | Skr- | Skr25.64 Million | ▼ -5.8 pp |
| 2019 | 9.0% | Skr986.78K | Skr986.78K | Skr- | Skr10.98 Million | — |